These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 6182767)
1. The biochemistry and pathophysiology of the contact system of plasma. Cochrane CG; Griffin JH Adv Immunol; 1982; 33():241-306. PubMed ID: 6182767 [No Abstract] [Full Text] [Related]
2. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets. Rao AK; Schmaier AH; Colman RW Pathobiol Annu; 1982; 12():35-64. PubMed ID: 6186978 [No Abstract] [Full Text] [Related]
3. Prekallikrein activation and kallikrein inactivation in human plasma. van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365 [No Abstract] [Full Text] [Related]
4. The contact activation system: biochemistry and interactions of these surface-mediated defense reactions. Colman RW; Schmaier AH Crit Rev Oncol Hematol; 1986; 5(1):57-85. PubMed ID: 3633772 [TBL] [Abstract][Full Text] [Related]
5. Major inhibitors of the contact phase coagulation factors. Schapira M Semin Thromb Hemost; 1987 Jan; 13(1):69-78. PubMed ID: 2436302 [No Abstract] [Full Text] [Related]
6. Complexes of Cl-inhibitor (Cl-INH) and hemostatic enzymes in normal plasma. Donaldson VH; Harrison RR Adv Exp Med Biol; 1983; 156():149-55. PubMed ID: 6602461 [No Abstract] [Full Text] [Related]
8. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629 [TBL] [Abstract][Full Text] [Related]
9. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors. Lämmle B; Griffin JH Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929 [TBL] [Abstract][Full Text] [Related]
10. Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. Kalter ES; Daha MR; ten Cate JW; Verhoef J; Bouma BN J Infect Dis; 1985 Jun; 151(6):1019-27. PubMed ID: 2582065 [TBL] [Abstract][Full Text] [Related]
11. Present knowledge on contact factors. Theoretical and practical aspects. Soulier JP; Gozin D Rev Fr Transfus Immunohematol; 1984 Dec; 27(6):785-805. PubMed ID: 6395283 [No Abstract] [Full Text] [Related]
12. The inhibition of activated factor XII (Hageman factor) by antithrombin III: the effect of other plasma proteinase inhibitors. Chan JY; Burrowes CE; Habal FM; Movat HZ Biochem Biophys Res Commun; 1977 Jan; 74(1):150-8. PubMed ID: 65173 [No Abstract] [Full Text] [Related]
14. Structural and functional characterization of factor XII. Tans G; Rosing J Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074 [TBL] [Abstract][Full Text] [Related]
15. [Role of the contact plasma system in human physiopathology]. Sánchez-Ibarrola A; Villaro J; Subirá ML Rev Esp Fisiol; 1989; 45 Suppl():233-8. PubMed ID: 2701761 [TBL] [Abstract][Full Text] [Related]
16. [Contact coagulation factors]. Kojima T; Saito H Rinsho Byori; 1987 Apr; Spec No 70():79-87. PubMed ID: 3302400 [No Abstract] [Full Text] [Related]
17. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording. Joist JH; Cowan JF; Khan M J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667 [TBL] [Abstract][Full Text] [Related]
18. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI. Kaplan AP Prog Hemost Thromb; 1978; 4():127-75. PubMed ID: 362477 [No Abstract] [Full Text] [Related]
19. A simple screening test for evaluating prolonged partial thromboplastin times in newborn infants. Andrew M; Karpatkin M J Pediatr; 1982 Oct; 101(4):610-2. PubMed ID: 7119968 [No Abstract] [Full Text] [Related]
20. [Physiological anticoagulants. Current data on the composition, function and clinical value]. Barkagan ZS; Bishevskii KM Lab Delo; 1978; (10):579-87. PubMed ID: 81906 [No Abstract] [Full Text] [Related] [Next] [New Search]